Screener
Celldex Therapeutics CLDX Operating Lease Liabilities
Operating Lease Liabilities at other companies
Other financials
Where this comes from
Reported directly by Celldex Therapeutics in its filing.
Tagged under the XBRL concept us-gaap:OperatingLeaseLiabilityNoncurrent.
The source filing: Celldex Therapeutics’s 10-Q, filed August 6, 2026.
- Filed
- Aug 6, 2026, 4:06 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001104659-26-091984
| Line item | June 30, 2026 | December 31, 2025 |
|---|---|---|
| Current portion of operating lease liabilities | 1,557 | 1,552 |
| Current portion of other long-term liabilities | 1,230 | 1,230 |
| Total current liabilities | 61,325 | 50,991 |
| Long-term portion of operating lease liabilities | 3,347 | 784 |
| Other long-term liabilities | 3,113 | 4,043 |
| Total liabilities | 67,785 | 55,818 |
| Commitments and contingent liabilities | ||
| Stockholders’ equity: |
Item 1. Unaudited Financial Statements
FAQ
- What is Celldex Therapeutics's operating lease liabilities?
- Celldex Therapeutics (CLDX) reported operating lease liabilities of $3.35M in Q2 2026.
- How has Celldex Therapeutics's operating lease liabilities changed year-over-year?
- Celldex Therapeutics's operating lease liabilities increased by 123.9% year-over-year, from $1.5M to $3.35M.
- What is the long-term trend for Celldex Therapeutics's operating lease liabilities?
- Over 5 years (2020 to 2025), Celldex Therapeutics's operating lease liabilities has grown at a -18.3% compound annual growth rate (CAGR), from $2.15M to $784K.
- What does operating lease liabilities mean?
- Long-term portion of operating lease obligations extending beyond one year, representing committed future rent payments.
Ask your AI about Celldex Therapeutics's operating lease liabilities.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude